David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3801
PUT
Pultegroup
PHM
$24.7B
| – | – |
-56,700
| Closed | -$1.47M |
|
3802
Polaris
PII
$3.66B
| – | – |
-5,284
| Closed | -$448K |
|
3803
CALL
POSCO
PKX
$17.8B
| – | – |
-20,000
| Closed | -$1.1M |
|
3804
CALL
Planet Fitness
PLNT
$4.12B
| – | – |
-8,200
| Closed | -$440K |
|
|
3805
PUT
Planet Fitness
PLNT
$4.12B
| – | – |
-14,600
| Closed | -$783K |
|
3806
CALL
PNC Financial Services
PNC
$96.8B
| – | – |
-48,200
| Closed | -$5.63M |
|
3807
Pinnacle West Capital
PNW
$11.8B
| – | – |
-175,629
| Closed | -$15M |
|
3808
CALL
Pool Corp
POOL
$6.82B
| – | – |
-15,000
| Closed | -$2.23M |
|
3809
PUT
Pilgrim's Pride
PPC
$7.61B
| – | – |
-21,200
| Closed | -$329K |
|
3810
PPG Industries
PPG
$25.2B
| – | – |
-1,968
| Closed | -$201K |
|
|
PPL
3811
PUT
PPL Corp
PPL
$26.3B
| – | – |
-10,400
| Closed | -$295K |
|
3812
CALL
Protolabs
PRLB
$1.87B
| – | – |
-33,000
| Closed | -$3.72M |
|
3813
ProQR Therapeutics
PRQR
$344M
| – | – |
-21,436
| Closed | -$338K |
|
3814
PUT
Prothena Corp
PRTA
$479M
| – | – |
-46,000
| Closed | -$474K |
|
3815
Pearson
PSO
$10B
| – | – |
-45,770
| Closed | -$546K |
|
3816
CALL
PTC
PTC
$16.7B
| – | – |
-12,700
| Closed | -$1.05M |
|
|
3817
PTC
PTC
$16.7B
| – | – |
-219,108
| Closed | -$18.2M |
|
|
3818
PUT
PTC
PTC
$16.7B
| – | – |
-10,300
| Closed | -$854K |
|
3819
PUT
Patterson-UTI
PTEN
$4.47B
| – | – |
-18,100
| Closed | -$187K |
|
|
BCIC
3820
BCP Investment Corp
BCIC
$95.1M
| – | – |
-1,041
| Closed | -$36K |
|
3821
Prudential
PUK
$35.4B
| – | – |
-31,963
| Closed | -$1.1M |
|
3822
ProPetro Holding
PUMP
$1.34B
| – | – |
-10,192
| Closed | -$126K |
|
3823
Quantum Corp
QMCO
$854M
| – | – |
-23,869
| Closed | -$955K |
|
3824
CALL
Ferrari
RACE
$74.4B
| – | – |
-7,600
| Closed | -$756K |
|
|
3825
Ferrari
RACE
$74.4B
| – | – |
-6,047
| Closed | -$741K |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.